Transcript Horizon 2020
Implementation of health research funding under H2020 SC 1- “Health, demographic change and wellbeing “
Elmar Nimmesgern PhD DG Research and Innovation European Commission Infoday IMI2 Ljubljana, 13 January 2014
What is Horizon 2020?
The EU’s 2014-20 programme for research & innovation A core part of Europe 2020, Innovation Union & European Research Area
http://ec.europa.eu/research/horizon2020
Funding
(million EUR, 2014-2020)
Health, demographic change and wellbeing Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the Bioeconomy Secure, clean and efficient energy * Smart, green and integrated transport Climate action, environment, resource efficiency and raw materials Inclusive, innovative and reflective societies Secure societies
Science with and for society Spreading excellence and widening participation
7 472 3 851 5 931 6 339 3 081 1 310 1 695
462 816
Horizon 2020 - Societal Challenge 1
• • • • •
Translating science to benefit citizens Improve health outcomes Support a competitive health & care sector Test and demonstrate new health & care models, approaches and tools Promote healthy and active ageing Also look elsewhere! EU support of health related research & innovation is not limited to Societal Challenge 1
New Approach Challenge-driven Broad topics Less prescriptive topic texts Two-year work programme Stronger focus on end users
More Opportunities for SMEs
• • • • • 20% of the total budget for societal challenges/LEITs to go to SMEs Simplification – a great benefit to SMEs A new SME instrument 'Innovation in SMEs' - a dedicated activity for research-intensive SMEs 'Access to risk finance' with strong SME focus (debt and equity facility) Image courtesy of Vlado/ FreeDigitalPhotos.net
Wanted: international cooperation
• • • • • •
A priority Key goal: more and better international cooperation Horizon 2020 is open to participation from across the world Targeted actions across the entire programme Horizon 2020 Regulation and Rules for Participation apply
Participants from USA can be funded in SC1 (but not other SCs)
Getting you started faster
• A single set of simpler and more coherent participation rules • New trust/control balance • Just 2 funding rates for different beneficiaries and activities (70 and 100%) • Single flat rate for overhead or 'indirect costs' (25%) •
Simpler financial regulation
to come •
8 months' time-to-grant
(exceptions for the ERC and in duly justified cases) Image courtesy of ponsuwan/ FreeDigitalPhotos.net
Horizon 2020 'Health, demographic change and wellbeing'
Strategic initiatives linked to SC1
Innovative Medicines Initiative 2
www.imi.europa.eu
European Innovation Partnership on Active and Healthy Ageing
https://webgate.ec.europa.eu/eipaha
Active and Assisted Living 2
www.aal-europe.eu
European & Developing Countries Clinical Trials Partnership (EDCTP2)
www.edctp.org
The SC1 work programme 2014/15 in brief Call 'personalising health and care'
34 topics (15 in 2014, 17 in 2015, 2 open in both years)
Call for 'co-ordination activities'
16 topics (10 in 2014, 6 in 2015)
€ 1,21 billion
Understanding the call topics: example 'PHC 2 – 2015' 'Specific challenge' 'Scope', includes estimated budget (not binding) 'Expected impact' 'Type of action'
Personalising health and care
Call 'personalising health and care' Seven focus areas
• • • • • • •
Understanding health, ageing & disease Effective health promotion, disease prevention, preparedness and screening Improving diagnosis Innovative treatments and technologies Advancing active and healthy ageing Integrated, sustainable, citizen-centred care Improving health information, data exploitation and providing an evidence base for health policies and regulation
From "omics" … to prevention
• • • • •
Inter-sector cooperation for environment- and health based interventions (2015; € 4-6 m, € 18 m total) Translating -omics into prevention and health promotion (2014; € 4-6 m, € 24 m total) Evaluating existing screening and prevention programmes (2014 ; € 2-3 m), € 15 m total) Control of infectious epidemics through rapid pathogen identification (2014; € 15-20 m, € 15+5 m total) Vaccine platforms for TB (2014) and HIV (2015) (€15-25 m for both topics, indicated € 25 m for 2014, € 21 m for 2015)
Co-ordination activities
Applying for funding – process in brief Publication of the calls Signature grant agreement
Time to prepare the proposal Preparation of the grant
Submission of proposals Evaluation Information on the outcome of the evaluator
Applying for funding – your one-stop shop